T1	Outcomes 575 597	maximum tolerated dose
T2	Outcomes 660 670	toxicities
T3	Outcomes 787 798	DCP levels,
T4	Outcomes 839 848	AFP level
T5	Outcomes 887 891	PRs,
T6	Outcomes 900 913	stable tumors
T7	Outcomes 928 946	tumor progression.
T8	Outcomes 996 1059	phosphorylation of JNK and c-Jun and caspase-mediated apoptosis